Dec 09, 2014
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $362.00 to $3620.00.
The split itself did not change the total investment value.
PharmGen Science, Inc. (KRX:004720) operates in the Pharmaceuticals: other industry.
PharmGen Science, Inc. company overviewPharmGen Science, Inc.'s most recent stock split was on December 9, 2014. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
PharmGen Science, Inc. (KRX:004720) has split its stock 4 times: a 10-for-1 split on March 10, 2006, a 277-for-260 split on May 6, 2009, a 295-for-278 split on July 24, 2012, and a 1-for-10 reverse split on December 9, 2014.
PharmGen Science, Inc. has split its stock 4 times. This history records 4 splits between March 10, 2006 and December 9, 2014.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In PharmGen Science, Inc.'s 1-for-10 reverse split on December 9, 2014, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
PharmGen Science, Inc. has not announced a new split in our records. Its most recent split was on December 9, 2014, 11 years ago. Companies announce splits in advance, and any new KRX:004720 split will appear on this page.
Already premium?